Active ingredient
Amphetamine
58 finished FDA listings contain Amphetamine as their only active ingredient; 231 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- AMPHETAMINE, AMPHETAMINE ASPARTATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AMPHETAMINE DL-ASPARTATE, AMPHETAMINE DL-ASPARTATE MONOHYDRATE, AMPHETAMINE SULFATE
- Dosage forms
- Suspension, Extended Release, Tablet, Tablet, Extended Release, Tablet, Orally Disintegrating
- Routes
- Oral
- Manufacturers / labelers
- 16
- Strengths listed
- 10 mg/1 · 12.5 mg/1 · 15 mg/1 · 15.7 mg/1 · 18.8 mg/1 · 2.5 mg/ml · 20 mg/1 · 3.1 mg/1 · 5 mg/1 · 6.3 mg/1 · 9.4 mg/1
- Brand names in FDA listings
- Adzenys Xr-Odt, Amphetamine Sulfate, Dyanavel Xr, Evekeo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 725
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 200166 | AZURITY | 2012-08-09 | 8 |
| NDA 208147 | TRIS PHARMA INC | 2015-10-19 | 1 |
| NDA 204326 | NEOS THERAPS | 2016-01-27 | 12 |
| ANDA 211139 | AMNEAL PHARMS | 2018-09-26 | 2 |
| ANDA 211639 | AUROLIFE PHARMA LLC | 2019-04-17 | 2 |
| ANDA 212619 | GRANULES | 2019-08-05 | 2 |
| ANDA 212582 | SANALUZ | 2020-02-04 | 2 |
| ANDA 211861 | PRINSTON INC | 2020-03-11 | 6 |
| ANDA 212901 | SENORES PHARMS | 2020-05-22 | 9 |
| ANDA 213980 | EPIC PHARMA LLC | 2020-10-27 | 2 |
| ANDA 213583 | SPECGX LLC | 2021-01-22 | 2 |
| NDA 210526 | TRIS PHARMA INC | 2021-11-04 | 4 |
| ANDA 209253 | ACTAVIS LABS FL INC | 2023-06-22 | 6 |
Official labeling on DailyMed
- AMPHETAMINE SULFATE TABLET [AUROLIFE PHARMA, LLC] · version 10 · 2026-08-21
- AMPHETAMINE TABLET, ORALLY DISINTEGRATING [TEVA PHARMACEUTICALS, INC.] · version 3 · 2026-08-20
- AMPHETAMINE SULFATE TABLET AMPHETAMINE SULFATE (AMPHETAMINE SULFATE TABLETS) TABLET [AMICI PHARMA, INC.] · version 1 · 2026-07-23
- AMPHETAMINE SULFATE (AMPHETAMINE SULFATE) TABLET [GRANULES PHARMACEUTICALS INC.] · version 14 · 2026-07-17
- AMPHETAMINE SULFATE TABLET [BRYANT RANCH PREPACK] · version 3 · 2026-04-02
- AMPHETAMINE SULFATE TABLET [BRYANT RANCH PREPACK] · version 3 · 2026-04-02
- DYANAVEL XR (AMPHETAMINE) SUSPENSION, EXTENDED RELEASE DYANAVEL XR (AMPHETAMINE) TABLET, EXTENDED RELEASE [NEXTWAVE PHARMACEUTICALS, INC] · version 14 · 2026-02-26
- AMPHETAMINE SULFATE TABLET [BRYANT RANCH PREPACK] · version 1 · 2026-02-06
- AMPHETAMINE SULFATE TABLET [WILSHIRE PHARMACEUTICALS, INC.] · version 6 · 2026-01-28
- AMPHETAMINE SULFATE TABLET [SPECGX LLC] · version 10 · 2025-12-22
- AMPHETAMINE SULFATE TABLET [EPIC PHARMA LLC] · version 7 · 2025-12-19
- EVEKEO (AMPHETAMINE SULFATE) TABLET [AZURITY PHARMACEUTICALS, INC.] · version 9 · 2025-11-17
Showing the 12 most recent of 25 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.